Literature DB >> 11080733

Determinants of the immune-inflammatory response in allergic airway inflammation: overview of antigen presentation and cellular activation.

S A Ritz1, B U Gajewska, M R Stämpfli, M Jordana.   

Abstract

Under normal circumstances the lung is in a state of immunologic homeostasis, a condition in which exposure to innocuous antigens does not lead to immune-inflammatory responses. This is the only reasonable solution to the dilemma faced by the lung: The need to interact with the external environment and the need to avoid responding to most of the environmental antigens to which it is exposed. In allergic diseases, such as asthma, this homeostasis is undermined, and immuneinflammatory responses to harmless aeroallergens are activated. We describe the changes in antigen presentation and cellular activation observed in a model of allergic airway inflammation. Further, we present a summary of our work that investigated the impact of the airway cytokine microenvironment on the development of immune responses in the respiratory tract.

Entities:  

Mesh:

Year:  2000        PMID: 11080733     DOI: 10.1067/mai.2000.110152

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

Review 1.  Allergen-induced generation of mediators in the mucosa.

Authors:  S Mattoli
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

Review 2.  Cellular and Molecular Events in the Airway Epithelium Defining the Interaction Between House Dust Mite Group 1 Allergens and Innate Defences.

Authors:  Jihui Zhang; Jie Chen; Clive Robinson
Journal:  Int J Mol Sci       Date:  2018-11-10       Impact factor: 5.923

3.  Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cells.

Authors:  Nicole M Kuderer; Homero G San-Juan-Vergara; Xiaoyuan Kong; Robert Esch; Richard F Lockey; Shyam S Mohapatra
Journal:  Clin Mol Allergy       Date:  2003-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.